KMC Speciality Hospitals (India) Ltd reported a strong start to FY2027, with Q1 net profit jumping 120% YoY to Rs 16.6 crore. Total income rose 39% to Rs 93.6 crore, driven by robust patient volumes and a 32.4% EBITDA margin. The company saw a 25% increase in in-patient volume and an 11% rise in ARPOB, reflecting improved operational efficiency across its specialties, particularly in Mother and Child Care.
KMC Speciality Hospitals Q1 Net Profit Jumps 120% YoY
Q1 PAT stood at Rs 16.6 crore compared to Rs 7.5 crore in the year-ago period.
Total income reached Rs 93.6 crore, marking a 38.9% growth over the previous year.
Reader Takeaway: Strong volume and ARPOB growth drive margin expansion; focus remains on maintaining occupancy in newer facilities.
What just happened
KMC Speciality Hospitals (India) posted robust results for the quarter ending June 30, 2026. The company significantly expanded its profitability, with EBITDA margins widening to 32.4% from 25.6%. This operational efficiency was bolstered by a 25% surge in occupied beds and an 11% increase in Blended ARPOB to Rs 34,214.
Why this matters
The results highlight the company's ability to scale operations profitably. With both in-patient and out-patient volumes growing by 25% and 31% respectively, the firm is successfully capturing increased demand. The Mother and Child Care segment remains a core contributor, accounting for 26% of total income.
Balance Sheet and Liquidity
As of June 30, 2026, the company maintains a stable financial position with a net worth of Rs 226.8 crore. While total borrowings stand at Rs 68.3 crore—primarily attributed to the "Maa Kauvery" facility—the company holds a strong cash balance and fixed deposits totaling Rs 81.2 crore.
Risks to watch
Investors should monitor the company's ability to sustain these margin levels as operational costs scale. Additionally, success in maintaining high occupancy rates at the new 200-bed facility will be crucial for long-term growth.
What to track next
Watch for consistent utilization trends at the new facility and whether the current momentum in ARPOB growth persists in the coming quarters.
